vTv Therapeutics (VTVT) Return on Sales (2014 - 2026)
vTv Therapeutics (VTVT) reported Return on Sales of 0.01% for Q1 2026, up 1348.0% on a YoY basis from 0.0% in Q1 2025, and up 100.04% sequentially from 16.69% in Q3 2025.
vTv Therapeutics (VTVT) Return on Sales (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 13 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 1348.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 1347.0% YoY), and the FY2024 full-year result was 0.22%, changed N/A from the prior year.
- Return on Sales improved to 0.01% in Q1 2026, from 16.69% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2026 to a low of 30.68% in Q3 2023.
- A 5-year average of 8.58% and a median of 4.55% in 2022 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales tumbled 3054 bps in 2023 and soared 3046 bps in 2024, its largest moves.
- Tracing VTVT's Return on Sales over 5 years: stood at 6.77% in 2022, then sank by 353 bps to 30.68% in 2023, then jumped by 91 bps to 2.61% in 2024, then sank by 540 bps to 16.69% in 2025, then surged by 100 bps to 0.01% in 2026.
- Business Quant data shows VTVT's Return on Sales at 0.01% in Q1 2026, 16.69% in Q3 2025, and 14.04% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01% |
| Sep 30, 2025 | -16.69% |
| Jun 30, 2025 | -14.04% |
| Mar 31, 2025 | -13.47% |
| Dec 31, 2024 | -2.61% |
| Sep 30, 2024 | -0.23% |
| Jun 30, 2024 | -0.25% |
| Mar 31, 2024 | -0.06% |
| Sep 30, 2023 | -30.68% |
| Jun 30, 2023 | -27.27% |
| Mar 31, 2023 | -11.90% |
| Dec 31, 2022 | -6.77% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | -4.55% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -10.54% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -0.93% |
| Mar 31, 2021 | -0.06% |
| Dec 31, 2020 | 0.00% |